Filings under SLXN by Sielox Inc (CIK 0001053676) from Apr 16, 2010 to Apr 16, 2010 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Shirvan Mitchell | CSO and CDO | Grant(A) | 6K | — | $0 |
| Jun 4, 2026 | Horenshtein Hadar Mirit | CFO and Secretary | Grant(A) | 8K | — | $0 |
| Jun 4, 2026 | Hadar Ilan | Chairman and CEO, Director | Grant(A) | 10K | — | $0 |
| Mar 26, 2026 | Shirvan Mitchell | CSO and CDO | Sell(S) | 23K | $1.36 | $31K |
| Feb 20, 2026 | Lushi Avner | Director | Grant(A) | 9K | — | $0 |
| Feb 20, 2026 | Lushi Avner | Director | Grant(A) | 11K | — | $0 |
| Feb 20, 2026 | Peled Amnon | Director | Grant(A) | 8K | — | $0 |
| Feb 20, 2026 | Peled Amnon | Director | Grant(A) | 9K | — | $0 |
| Feb 20, 2026 | Abramov Dror Yosef | Director | Grant(A) | 9K | — | $0 |
| Feb 20, 2026 | Abramov Dror Yosef | Director | Grant(A) | 11K | — | $0 |
| Feb 20, 2026 | Hadar Ilan | Chairman and CEO, Director | Grant(A) | 64K | — | $0 |
| Feb 20, 2026 | Horenshtein Hadar Mirit | CFO and Secretary | Grant(A) | 50K | — | $0 |
| Feb 20, 2026 | Shirvan Mitchell | CSO and CDO | Grant(A) | 50K | — | $0 |
| Feb 20, 2026 | Alon Ruth | Director | Grant(A) | 9K | — | $0 |
| Feb 20, 2026 | Alon Ruth | Director | Grant(A) | 11K | — | $0 |
| Feb 20, 2026 | Noy Shlomo | Director | Grant(A) | 9K | — | $0 |
| Feb 20, 2026 | Noy Shlomo | Director | Grant(A) | 11K | — | $0 |
| Sep 15, 2025 | Moringa Sponsor, LP | 10% Owner | Grant(A) | 450K | $4.00 | $1.8M |
| Aug 7, 2025 | Moringa Sponsor, LP | 10% Owner | Other(J) | 6K | — | $0 |
| Aug 7, 2025 | Moringa Sponsor, LP | 10% Owner | Other(J) | 935 | — | $0 |
| Feb 9, 2025 | Peled Amnon | Director | Grant(A) | 661 | — | $0 |
| Feb 9, 2025 | Peled Amnon | Director | Grant(A) | 780 | — | $0 |
| Feb 9, 2025 | Lushi Avner | Director | Grant(A) | 2K | — | $0 |
| Feb 9, 2025 | Lushi Avner | Director | Grant(A) | 2K | — | $0 |
| Feb 9, 2025 | Noy Shlomo | Director | Grant(A) | 2K | — | $0 |
| Feb 9, 2025 | Noy Shlomo | Director | Grant(A) | 2K | — | $0 |
| Feb 9, 2025 | Alon Ruth | Director | Grant(A) | 794 | — | $0 |
| Feb 9, 2025 | Alon Ruth | Director | Grant(A) | 935 | — | $0 |
| Feb 9, 2025 | Abramov Dror Yosef | Director | Grant(A) | 794 | — | $0 |
| Feb 9, 2025 | Abramov Dror Yosef | Director | Grant(A) | 935 | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Silexion Therapeutics Corp, SEC CIK 0002022416. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under SLXN and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for SLXN